Globe Newswire » trang 32 » Trang Công Nghệ | Trangcongnghe.vn

Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma

Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma

Globenewswire -

First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix

First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix

Globenewswire -

TYLin Group Announces Strategic Leadership Appointment - Jenni Roseleip as Chief Marketing Officer

TYLin Group Announces Strategic Leadership Appointment - Jenni Roseleip as Chief Marketing Officer

Globenewswire -

WeightWatchers Appoints SoulCycle Co-Founder Julie Rice as Chief Experience Officer to Lead Community and Brand Innovation

Globenewswire -

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

Globenewswire -

Rubicon Point Partners Announces First Close of Rubicon Point Fund II

Rubicon Point Partners Announces First Close of Rubicon Point Fund II

Globenewswire -

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

Globenewswire -

XEM THÊM TIN MỚI